GlassScriptPhysician profile
Parker Nelson Ward
NPI 1326720087
$7,071.56
in general payments reported to CMS, 2019-2025
23 companies · $4,584 in 2025
The $4,584 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,487 · 2025: $4,584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,813 · Education: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,812.59 |
| Education | $258.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,635.03 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $1,163.70 | 2024-2025 | |
| Janssen Biotech, INC. | $910.24 | 2024-2025 | Tremfya |
| Incyte Corporation | $545.88 | 2024-2025 | Opzelura, Opzelura |
| Arcutis Biotherapeutics, INC. | $370.53 | 2024-2025 | Zoryve |
| Dermavant Sciences, INC. | $366.65 | 2024 | Vtama |
| Regeneron Healthcare Solutions, INC. | $318.86 | 2024-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $307.70 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $251.96 | 2025 | |
| Ucb, INC. | $219.78 | 2025 | Bimzelx |
| Amgen INC. | $213.38 | 2024-2025 | Otezla, Otezla |
| Organon LLC | $157.89 | 2025 | Vtama |
| Lilly USA, LLC | $148.86 | 2024-2025 | Ebglyss, Taltz, Olumiant |
| Leo Pharma INC. | $115.02 | 2024-2025 | Adbry, Anzupgo |
| Botanix Sb INC | $106.87 | 2025 | Sofdra |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lnhc, INC | $42.81 | 2025 | Zelsuvmi |
| Pfizer INC. | $42.62 | 2024 | |
| Galderma Laboratories, L.P. | $33.45 | 2025 | Nemluvio |
| Mayne Pharma Commercial LLC | $31.58 | 2024 | |
| Springworks Therapeutics, INC. | $29.08 | 2025 | Gomekli |
| E.R. Squibb & Sons, L.L.C. | $25.00 | 2025 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.49 | 2024 | Cabtreo, Jublia |
| Almirall LLC | $14.18 | 2025 | Seysara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parker Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.